Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Capital Expenditures: 2023-2025

Historic Capital Expenditures for Camp4 Therapeutics (CAMP) over the last 1 years, with Mar 2025 value amounting to $279,000.

  • Camp4 Therapeutics' Capital Expenditures rose 84.77% to $279,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $720,000, marking a year-over-year change of. This contributed to the annual value of $441,000 for FY2024, which is 34.96% down from last year.
  • Latest data reveals that Camp4 Therapeutics reported Capital Expenditures of $279,000 as of Q1 2025, which was up 6.08% from $263,000 recorded in Q4 2024.
  • In the past 5 years, Camp4 Therapeutics' Capital Expenditures registered a high of $279,000 during Q1 2025, and its lowest value of $27,000 during Q2 2024.
  • Moreover, its 3-year median value for Capital Expenditures was $243,000 (2023), whereas its average is $192,600.
  • Data for Camp4 Therapeutics' Capital Expenditures shows a peak YoY surged of 84.77% (in 2025) over the last 5 years.
  • Over the past 3 years, Camp4 Therapeutics' Capital Expenditures (Quarterly) stood at $243,000 in 2023, then increased by 8.23% to $263,000 in 2024, then spiked by 84.77% to $279,000 in 2025.
  • Its Capital Expenditures was $279,000 in Q1 2025, compared to $263,000 in Q4 2024 and $27,000 in Q2 2024.